PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study-Reference-Cited by-同舟云学术

PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study

Published:2023-03 Issue: Volume:159 Page:114220
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Salgüero Sergio,Brochado-Kith Óscar,Verdices Ana Virseda,Berenguer Juan,González-García Juan,Martínez Isidoro,Díez Cristina,Hontañón Víctor,Pérez-Latorre Leire,Fernández-Rodríguez Amanda,Jiménez-Sousa María Ángeles,Resino Salvador

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference60 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;The Polaris Observatory HCV Collaborators;Lancet Gastroenterol. Hepatol.,2017

2. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat. Rev. Gastroenterol. Hepatol.,2013

3. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection;Vallet-Pichard;J. Hepatol.,2006

4. Natural history of liver disease and effect of hepatitis C virus on HIV disease progression;Ingiliz;Curr. Opin. HIV AIDS,2015

5. Pathogenesis of liver fibrosis;Hernandez-Gea;Annu. Rev. Pathol.: Mech. Dis.,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling the organ membrane proteome dysregulation in the context of liver disease;2024-04-09

2. Corrigendum to “PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study” [Biomed. Pharmacother. 159 (2023) 114220];Biomedicine & Pharmacotherapy;2023-07